Schuster SJ, Bishop MR, Tam C, et al. Sustained disease control for adult patients with relapsed or refractory diffuse large B-cell lymphoma: an updated analysis of Juliet, a global pivotal phase 2 trial of tisagenlecleucel. ASH Annual Meeting and Exposition 2018, abstract 1684.
Verbeterde overleving met axicabtagene ciloleucel bij grootcellig B-cellymfoom: ZUMA-7
okt 2023 | Lymfoom